Transcat Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 21 out of 58 in the Electronic Equipment & Parts industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 101.33.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Transcat Inc's Score
Industry at a Glance
Industry Ranking
21 / 58
Overall Ranking
134 / 4521
Industry
Electronic Equipment & Parts
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Transcat Inc Highlights
StrengthsRisks
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.75% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 278.42M.
Undervalued
The company’s latest PB is 2.40, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.11M shares, decreasing 13.86% quarter-over-quarter.
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.